Another Diabetes Competitor Approved

If you have to be critical...please list all the Merck products that were truly from MSDRL and which were licensed.

Then do share with us a list of companies that have never acquired nor licensed anything from the outside?

Apple, Google, Facebook, etc, always acquire companies with technologies/products they want. is that a problem for you too?

 

Exactly my point. Merck is always touting how it is this great research company ( and it used to be) when most of its " research" came from someone else. Nothing wrong with acquisitions it's how things are done and products come to market and all companies acquire and co-promote, etc. but Merck always held its self as above that, and I heard management once say " we are Merck, we are research driven, we don't co-promote" when they clearly do.
If memory serves, Singulair came from a Canadian company, Fosamax from an Italian company, cozaar and Prinivil were licensed from other companies. Again, nothing wrong with that, as a matter of fact Merck now seems to have trouble either bringing their own research to market OR licensing OR acquiring new products. I wonder why that is? The companies that they acquired ( probably even SP) product lines all fell through. I wonder why that is?

 

Better go check your history on those...then name me any other company in the business....their breakthrough new science products and where they came from....Noroxin (Japs) was not listed...Pepcid (Japs) was not listed...few products and actual classes of products...most everyone else can only copy...hell whole companies like Forrest and Marion Labs never discovered anything only bought copies from someone else and sold everyday....nothing wrong with that but had Merck not given away the patent on freeze drying and bulk production Pfizer would still have made penicillin in two million bell jars in run down buildings in Brooklyn!

 

Why argue over the minute details?
Pepcid and Noroxin are licensed from the same Japanese company (Yamanouchi which has since then merged with Fujisawa to form Astella) for the US market. We never did as well versus Zantac but the JV with J&J is a huge success selling OTC Pepcid.
Singulair - actually home grown.
The Italian company Instituto Gentili licensed Fosamax to Merck and the latter eventually bought the entire company out.
Cozaar and Hyzaar were discovered by DuPont and marketed by Merck. There was a DuPont Merck JV for awhile.

Heck you can go back further when Astra asked Merck to help them get Prilosec to the US market. There was an Astra Merck JV for awhile too. Even after Astra bought back all interests in Prilosec, and if you ever tour West Point, you'll see Merck continues to manufacture the commercial product and box samples for them.

All these companies cross license to each other for different reasons. Some co-promote with their usual enemies (money speaks).

 

Why drone on about more minute details? Like..so what!

 

Back to the topic at hand: Merck will co-develop an sglt2 with Pfizer but by the time they get it to market it will be meaningless. " day late and dollar short" comes to mind.

 

Quit pretending to be a Little Professor and just sell the drug.

Why so many reps act like they are physicians or scientists? Especially those who could not get into medical school or were in pre-med, or drop out of med school and became reps.

 

We actually sold assloads of Pepcid but we never dedicated a salesforce to promote it! Pepcid outsold Tagamet and Zantac in IV for many years...they almost gave up...we even beat the dreaded pharmacy management gurus' in Houston...the only real loser in the H2 market was AXID which Lilly almost dumped after an entire salesforce could not budge it! We've joined up with lots of folks and every company has...some only fish and never develop anything but mouths!

 

Acid wasn't a loser. It had more sales than the whole Quaker company.

 

Axid did achieve some success by low-balling everyone else. Lilly practically gave it away.

We did exceptionally well with the JV with J&J selling Pepcid AC because they are better in promoting OTC products.

 

Why? We have a lot of poorly informed reps here who think other companies do not get into M&A, cross licensing, licensing, re-branding, combination, etc.

 

Why do we have commercials with Pancreatitis and pancreatic ca? If there are studies that prove the association is insignificant and is a class effect for all DDP4s, then what is the big deal? There is Black Box Warning so why are we STILL doing things to kill the franchise?

 

It is only insignificant if you are not one of the few individuals that are susceptible to this risk. Possible adverse events must be disclosed in television advertisements.

 

Plus if you can get the same results or better ( which you can) with something else then why even risk it? It's just one less thing you have to explain to the patient.

 

Lilly, AZ and CSOs getting some of Merck exit reps. Stability?
Doubt if it's here, there ...nowhere any more ......new products or not!